Remove Disease Remove Pharmacogenetics Remove Research Remove Treatment
article thumbnail

Open Targets Platform 23.12 has been released!

The Open Targets Blog

The new page can be accessed from the target-disease associations page when searching for targets associated with a disease, and clicking on the target prioritisation factors tab. Target prioritisation view for Crohn's Disease. Clicking on one of the cells will bring up the data informing the assessment.

article thumbnail

A personal touch: the role of bioprinting in drug discovery

Drug Discovery World

The company hopes that through its technology, academics, life science industries and pharma industries can test and develop more personalised treatments for intricate tissue engineering and cell therapy, such as repairing damaged tissue, replacing lost biological functions, localised therapeutic solutions and complex drug formulations. .

article thumbnail

The use-case for NGS

Drug Discovery World

DDW Editor Reece Armstrong speaks to Dr Darrell Green , Lecturer in RNA Biology Biomedical Research Centre Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is impacting within drug discovery and development.